COVID-19 Incidence and Death Rate in Epilepsy: Too Early to Tell?

Comment

David G Vossler. Epilepsy Curr. 2021.

. 2021 Apr 30;21(4):261-263.

doi: 10.1177/15357597211014195. eCollection 2021 Jul-Aug.

No abstract available

Comment on

Incidence and case fatality rate of COVID-19 in patients with active epilepsy.
Cabezudo-García P, Ciano-Petersen NL, Mena-Vázquez N, Pons-Pons G, Castro-Sánchez MV, Serrano-Castro PJ. Cabezudo-García P, et al. Neurology. 2020 Sep 8;95(10):e1417-e1425. doi: 10.1212/WNL.0000000000010033. Epub 2020 Jun 17. Neurology. 2020. PMID: 32554773

1. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018–1027. doi:10.1001/jamaneurol.2020.2065 - PMC - PubMed
1. Wang C, Zhang M, Garcia G, Jr, et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell. 2021;28(2):331–342 e5. doi:10.1016/j.stem.2020.12.018 - PMC - PubMed
1. Ramani A, Pranty AI, Gopalakrishnan J. Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids. Stem Cell Reports. 2021;16(3):373–384. doi:10.1016/j.stemcr.2021.02.007 - PMC - PubMed
1. Pellinen J, Carroll E, Friedman D, et al. Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system. Epilepsia. 2020;61(10):2097–2105. doi:10.1111/epi.16667 - PubMed
1. Rosengard JL, Donato J, Ferastraoaru V, et al. Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: the patient perspective. Epilepsia. 2021;62(1):41–50. doi:10.1111/epi.16779 - PMC - PubMed